-
- Denis Moro-Sibilot, Léonie Ferrer, Matteo Giaj Levra, and Anne Claire Toffart.
- UM Oncologie Thoracique, Clinique de pneumologie, PTV CHU Grenoble-Alpes, CS10217 38043 Grenoble cedex; Inserm U823, Institut Albert Bonniot, Rond-point de la chantourne 38700 La tronche. Electronic address: dmorot-sibilot@chu-grenoble.fr.
- Bull Cancer. 2016 Jun 1; 103 (6 Suppl 1): S12-5.
Treatment Of Nsclc With NivolumabChemotherapy with docetaxel has remained a cornerstone of second-line treatment for more than 15 years, but it is associated with an unfavorable safety profile. Recently, the results of 2 randomized phase III trials assessing nivolumab in lung cancer, Check-Mate-017 and Check- Mate-057, have deeply changed our current clinical practice and open the debate for further improvements in the clinical care of lung cancer. This paper explores the recent findings about nivolumab in the second-line setting and discusses future directions for nivolumab and other immune Oncology drugs.© 2016 Société Française du Cancer. Publié par Elsevier Masson SAS.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..